DIA 2013 49th Annual Meeting
Click here to go to the previous page
Effective Diverse Team Collaboration and Management for Drug Development: Key Commonalities and Differences among Korea, China and Japan
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 227
Date: Tuesday, June 25, 2013
Time: 10:15 AM to 11:45 AM  EST
Location: 104C
CHAIR :
Atsushi Tsukamoto, PhD,MSc,PMP (SCHNON), Senior Director, Global Project Management, Daiichi Sankyo Co., Ltd., Japan
SPEAKER (S):
Atsushi Tsukamoto, MSc,PMP, Senior Director, Global Project Management, Daiichi Sankyo Co., Ltd., Japan
 Gareth Julian Monteath, MBA,MS (SPKNON), Program Director, Link Global Solution Inc., Japan
 Robert A. Hilke, MA (SPKNON), CEO, Hilke Communications Corporation, Japan
Description
Growing opportunities for drug development in Asian countries have drawn attention to those countries from the West, and also from other Asian countries. Although some of the traditional cultural styles are considered to be shared within Asia (i.e., Confucian rather than Socratic), other aspects, such as historical background, values and business styles, are very different among Korea, China and Japan. In this session, we will introduce typical pitfalls when working with Asian countries, especially in drug development, together with a framework to understand the commonalities and differences, in order to help the attendees with effective and efficient management of diverse Asian teams.